BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26482827)

  • 21. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
    Shah NR; Shah A; Rather A
    J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiotoxicity of 5-fluorouracil.
    Collins C; Weiden PL
    Cancer Treat Rep; 1987; 71(7-8):733-6. PubMed ID: 3300968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute heart failure after treatment with 5-fluorouracil.
    Georgieva S; Kinova E; Iordanov V; Gudev A; Tzekova V; Velikova M
    J BUON; 2007; 12(1):113-6. PubMed ID: 17436411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.
    Akpek G; Hartshorn KL
    Cancer Chemother Pharmacol; 1999; 43(2):157-61. PubMed ID: 9923822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The need for routine monitoring of cardiac function in patients receiving 5-fluorouracil infusion.
    Francis N
    Clin J Oncol Nurs; 2014 Jun; 18(3):360-2. PubMed ID: 24867118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil.
    Eskilsson J; Albertsson M
    Acta Oncol; 1990; 29(8):1001-3. PubMed ID: 2278719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
    Tsibiribi P; Descotes J; Lombard-Bohas C; Barel C; Bui-Xuan B; Belkhiria M; Tabib A; Timour Q
    Bull Cancer; 2006 Mar; 93(3):E27-30. PubMed ID: 16567310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Various Manifestations of 5-Fluorouracil Cardiotoxicity: A Multicenter Case Series and Review of Literature.
    Allison JD; Tanavin T; Yang Y; Birnbaum G; Khalid U
    Cardiovasc Toxicol; 2020 Aug; 20(4):437-442. PubMed ID: 31925673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
    Maurer U; Härle M; Jungius KP
    Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiotoxicity of 5-fluorouracil.
    Alter P; Herzum M; Soufi M; Schaefer JR; Maisch B
    Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):1-5. PubMed ID: 16529545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
    Shaib W; Lee V; Saif MW
    In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coronary artery disease attack caused by cytotoxic chemotherapy].
    Ilveskoski E; Nikus K; Tanner M; Eskola M
    Duodecim; 2009; 125(9):997-1001. PubMed ID: 19517869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoropyrimidine-Associated Cardiotoxicity.
    Kanduri J; More LA; Godishala A; Asnani A
    Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.
    Muneoka K; Shirai Y; Yokoyama N; Wakai T; Hatakeyama K
    Int J Clin Oncol; 2005 Dec; 10(6):441-3. PubMed ID: 16369751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiotoxicity of 5-fluorouracil].
    Teixeira L; Barry S; Debourdeau P; Cohen A; Tournigand C
    Bull Cancer; 2004 Nov; 91 Suppl 3():154-8. PubMed ID: 15899622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptomatic 5-fluorouracil-induced sinus bradycardia.
    Lee AD; McKay MJ
    Intern Med J; 2011 Jul; 41(7):566-70. PubMed ID: 21762335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.
    Farina A; Malafronte C; Valsecchi MA; Achilli F
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):722-6. PubMed ID: 19584743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction.
    Scott PA; Ferchow L; Hobson A; Curzen NP
    Emerg Med J; 2008 Oct; 25(10):699-700. PubMed ID: 18843078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capecitabine-induced ventricular fibrillation arrest: Possible Kounis syndrome.
    Kido K; Adams VR; Morehead RS; Flannery AH
    J Oncol Pharm Pract; 2016 Apr; 22(2):335-40. PubMed ID: 25870182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.